pollen health limited
pollen health limited Company Information
Company Number
07839170
Next Accounts
Dec 2025
Shareholders
health hive group ltd
Group Structure
View All
Industry
Advertising agencies
Registered Address
the featherstone building, 66 city road, london, EC1Y 2AL
Website
www.pollenhealth.compollen health limited Estimated Valuation
Pomanda estimates the enterprise value of POLLEN HEALTH LIMITED at £1.7m based on a Turnover of £3.8m and 0.45x industry multiple (adjusted for size and gross margin).
pollen health limited Estimated Valuation
Pomanda estimates the enterprise value of POLLEN HEALTH LIMITED at £2.3m based on an EBITDA of £779.4k and a 2.9x industry multiple (adjusted for size and gross margin).
pollen health limited Estimated Valuation
Pomanda estimates the enterprise value of POLLEN HEALTH LIMITED at £6.5m based on Net Assets of £3.7m and 1.76x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pollen Health Limited Overview
Pollen Health Limited is a live company located in london, EC1Y 2AL with a Companies House number of 07839170. It operates in the advertising agencies sector, SIC Code 73110. Founded in November 2011, it's largest shareholder is health hive group ltd with a 100% stake. Pollen Health Limited is a established, small sized company, Pomanda has estimated its turnover at £3.8m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pollen Health Limited Health Check
Pomanda's financial health check has awarded Pollen Health Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
5 Weak
Size
annual sales of £3.8m, make it smaller than the average company (£7.2m)
£3.8m - Pollen Health Limited
£7.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 22%, show it is growing at a faster rate (9.1%)
22% - Pollen Health Limited
9.1% - Industry AVG
Production
with a gross margin of 34.9%, this company has a comparable cost of product (42.1%)
34.9% - Pollen Health Limited
42.1% - Industry AVG
Profitability
an operating margin of 20.7% make it more profitable than the average company (4.7%)
20.7% - Pollen Health Limited
4.7% - Industry AVG
Employees
with 18 employees, this is below the industry average (35)
18 - Pollen Health Limited
35 - Industry AVG
Pay Structure
on an average salary of £126.7k, the company has a higher pay structure (£63.4k)
£126.7k - Pollen Health Limited
£63.4k - Industry AVG
Efficiency
resulting in sales per employee of £208.9k, this is more efficient (£179.2k)
£208.9k - Pollen Health Limited
£179.2k - Industry AVG
Debtor Days
it gets paid by customers after 21 days, this is earlier than average (53 days)
21 days - Pollen Health Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 16 days, this is quicker than average (43 days)
16 days - Pollen Health Limited
43 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Pollen Health Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (16 weeks)
0 weeks - Pollen Health Limited
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 68.4%, this is a similar level of debt than the average (65.3%)
68.4% - Pollen Health Limited
65.3% - Industry AVG
POLLEN HEALTH LIMITED financials
Pollen Health Limited's latest turnover from March 2024 is £3.8 million and the company has net assets of £3.7 million. According to their latest financial statements, Pollen Health Limited has 18 employees and maintains cash reserves of £126.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Jul 2020 | Jul 2019 | Aug 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Aug 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3,760,832 | 4,098,897 | 3,606,767 | 2,086,382 | 2,729,069 | 2,370,964 | 2,266,521 | 931,347 | 1,514,670 | 823,152 | 253,698 | 682,546 | |
| Other Income Or Grants | |||||||||||||
| Cost Of Sales | 2,446,716 | 2,387,150 | 1,846,530 | 1,051,954 | 1,678,769 | 1,411,573 | 1,570,234 | 942,919 | 371,213 | 53,324 | 241 | 74,479 | |
| Gross Profit | 1,314,116 | 1,711,747 | 1,760,237 | 1,034,428 | 1,050,300 | 959,391 | 696,287 | -11,572 | 1,143,457 | 769,828 | 253,457 | 608,067 | |
| Admin Expenses | 534,905 | 637,574 | 401,873 | 547,444 | 676,384 | 588,226 | 364,431 | 920,126 | 734,278 | 301,234 | |||
| Operating Profit | 779,211 | 1,074,173 | 632,555 | 502,856 | 283,007 | 108,061 | -376,003 | 223,331 | 35,550 | -47,777 | |||
| Interest Payable | |||||||||||||
| Interest Receivable | 6,380 | 18,520 | 124 | 422 | 56 | ||||||||
| Pre-Tax Profit | 830,506 | 1,074,173 | 1,057,462 | 632,555 | 2,348,087 | 289,387 | 126,581 | -375,879 | 223,753 | 35,606 | -47,777 | 69,185 | |
| Tax | -71,623 | 458 | 82,349 | -88,028 | -95,212 | -55,199 | -30,214 | 53,590 | -49,058 | -7,189 | 10,217 | -14,478 | |
| Profit After Tax | 758,883 | 1,074,631 | 1,139,811 | 544,527 | 2,252,875 | 234,188 | 96,367 | -322,289 | 174,695 | 28,417 | -37,560 | 54,707 | |
| Dividends Paid | 500,000 | 1,845,231 | 1,844,967 | ||||||||||
| Retained Profit | 758,883 | 1,074,631 | 1,139,811 | 44,527 | 407,644 | -1,610,779 | 96,367 | -322,289 | 174,695 | 28,417 | -37,560 | 54,707 | |
| Employee Costs | 2,280,569 | 1,804,840 | 1,611,997 | 898,560 | 1,396,771 | 1,458,746 | 1,325,763 | 1,332,641 | 362,984 | 299,438 | 143,935 | 255,425 | |
| Number Of Employees | 18 | 20 | 18 | 13 | 7 | 17 | 12 | 8 | 7 | 5 | 4 | ||
| EBITDA* | 779,389 | 1,074,481 | 632,665 | 503,044 | 284,735 | 111,369 | -374,013 | 225,299 | 37,804 | -46,666 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Jul 2020 | Jul 2019 | Aug 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Aug 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 6 | 184 | 492 | 577 | 244 | 169 | 1,896 | 1,630 | 3,400 | 1,415 | 3,265 | 2,965 | 3,794 |
| Intangible Assets | 1 | 49 | 261 | 493 | |||||||||
| Investments & Other | 1,495 | 955 | 497 | ||||||||||
| Debtors (Due After 1 year) | |||||||||||||
| Total Fixed Assets | 1,501 | 1,139 | 989 | 577 | 244 | 169 | 1,897 | 1,679 | 3,661 | 1,908 | 3,265 | 2,965 | 3,794 |
| Stock & work in progress | |||||||||||||
| Trade Debtors | 226,635 | 358,769 | 419,243 | 395,188 | 857,738 | 436,384 | 372,025 | 13,645 | 160,634 | 40,462 | 16,341 | 45,070 | 64,392 |
| Group Debtors | 10,035,914 | 4,289,849 | 961,585 | 62,491 | 570,641 | 550,424 | 1,738,980 | 389,193 | 413,401 | 60,320 | 6,953 | 142,371 | |
| Misc Debtors | 1,237,012 | 1,356,549 | 916,282 | 788,008 | 381,997 | 300,120 | 776,962 | 287,398 | 319,438 | 179,174 | 48,376 | 64,762 | |
| Cash | 126,416 | 834,112 | 661,251 | 502,628 | 390,245 | 48,648 | 133,002 | 60,194 | 33,563 | 4,427 | 51,170 | 29,768 | 55,687 |
| misc current assets | |||||||||||||
| total current assets | 11,625,977 | 6,839,279 | 2,958,361 | 1,748,315 | 2,200,621 | 1,335,576 | 3,020,969 | 750,430 | 927,036 | 284,383 | 122,840 | 281,971 | 120,079 |
| total assets | 11,627,478 | 6,840,418 | 2,959,350 | 1,748,892 | 2,200,865 | 1,335,745 | 3,022,866 | 752,109 | 930,697 | 286,291 | 126,105 | 284,936 | 123,873 |
| Bank overdraft | |||||||||||||
| Bank loan | |||||||||||||
| Trade Creditors | 111,924 | 7,424 | 24,679 | 11,221 | 60,563 | 3,246 | 67,127 | 5,984 | 56,961 | 25 | 5,771 | 14,790 | 106,108 |
| Group/Directors Accounts | 6,751,335 | 2,725,269 | 1,587 | 96,888 | 820,679 | 681,095 | 2,622,266 | 775,667 | 364,623 | 129,202 | 9,804 | ||
| other short term finances | |||||||||||||
| hp & lease commitments | |||||||||||||
| other current liabilities | 1,090,323 | 1,192,712 | 1,092,702 | 932,559 | 663,579 | 403,004 | 319,261 | 52,613 | 268,979 | 91,625 | 73,508 | 192,971 | |
| total current liabilities | 7,953,582 | 3,925,405 | 1,118,968 | 1,040,668 | 1,544,821 | 1,087,345 | 3,008,654 | 834,264 | 690,563 | 220,852 | 89,083 | 207,761 | 106,108 |
| loans | |||||||||||||
| hp & lease commitments | |||||||||||||
| Accruals and Deferred Income | |||||||||||||
| other liabilities | 2,593 | ||||||||||||
| provisions | 7,653 | ||||||||||||
| total long term liabilities | 7,653 | 2,593 | |||||||||||
| total liabilities | 7,953,582 | 3,925,405 | 1,118,968 | 1,048,321 | 1,544,821 | 1,087,345 | 3,008,654 | 834,264 | 690,563 | 220,852 | 89,083 | 210,354 | 106,108 |
| net assets | 3,673,896 | 2,915,013 | 1,840,382 | 700,571 | 656,044 | 248,400 | 14,212 | -82,155 | 240,134 | 65,439 | 37,022 | 74,582 | 17,765 |
| total shareholders funds | 3,673,896 | 2,915,013 | 1,840,382 | 700,571 | 656,044 | 248,400 | 14,212 | -82,155 | 240,134 | 65,439 | 37,022 | 74,582 | 17,765 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Jul 2020 | Jul 2019 | Aug 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Aug 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | 779,211 | 1,074,173 | 632,555 | 502,856 | 283,007 | 108,061 | -376,003 | 223,331 | 35,550 | -47,777 | |||
| Depreciation | 178 | 308 | 301 | 110 | 188 | 1,728 | 3,260 | 1,778 | 1,736 | 1,980 | 1,111 | 1,599 | 3,742 |
| Amortisation | 48 | 212 | 232 | 274 | |||||||||
| Tax | -71,623 | 458 | 82,349 | -88,028 | -95,212 | -55,199 | -30,214 | 53,590 | -49,058 | -7,189 | 10,217 | -14,478 | |
| Stock | |||||||||||||
| Debtors | 5,494,394 | 3,708,057 | 1,051,423 | -564,689 | 523,448 | -1,601,039 | 2,197,731 | -203,237 | 613,517 | 208,286 | -180,533 | 187,811 | 64,392 |
| Creditors | 104,500 | -17,255 | 13,458 | -49,342 | 57,317 | -63,881 | 61,143 | -50,977 | 56,936 | -5,746 | -9,019 | -91,318 | 106,108 |
| Accruals and Deferred Income | -102,389 | 100,010 | 160,143 | 268,980 | 260,575 | 83,743 | 266,648 | -216,366 | 177,354 | 18,117 | -119,463 | 192,971 | |
| Deferred Taxes & Provisions | -7,653 | 7,653 | |||||||||||
| Cash flow from operations | -4,784,517 | -2,550,363 | 1,336,617 | 202,276 | 1,850,437 | -1,788,785 | -384,529 | -202,986 | -165,300 | 15,602 | |||
| Investing Activities | |||||||||||||
| capital expenditure | |||||||||||||
| Change in Investments | 540 | 458 | 497 | ||||||||||
| cash flow from investments | |||||||||||||
| Financing Activities | |||||||||||||
| Bank loans | |||||||||||||
| Group/Directors Accounts | 4,026,066 | 2,723,682 | -95,301 | -723,791 | 139,584 | -1,941,171 | 1,846,599 | 411,044 | 235,421 | 119,398 | 9,804 | ||
| Other Short Term Loans | |||||||||||||
| Long term loans | |||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||
| other long term liabilities | -2,593 | 2,593 | |||||||||||
| share issue | |||||||||||||
| interest | 6,380 | 18,520 | 124 | 422 | 56 | ||||||||
| cash flow from financing | 4,026,066 | 2,723,682 | -95,301 | -723,791 | 139,584 | -89,824 | 1,865,119 | 411,168 | 235,843 | 119,454 | 7,211 | 4,703 | |
| cash and cash equivalents | |||||||||||||
| cash | -707,696 | 172,861 | 158,623 | 112,383 | 341,597 | -84,354 | 72,808 | 26,631 | 29,136 | -46,743 | 21,402 | -25,919 | 55,687 |
| overdraft | |||||||||||||
| change in cash | -707,696 | 172,861 | 158,623 | 112,383 | 341,597 | -84,354 | 72,808 | 26,631 | 29,136 | -46,743 | 21,402 | -25,919 | 55,687 |
pollen health limited Credit Report and Business Information
Pollen Health Limited Competitor Analysis
Perform a competitor analysis for pollen health limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in EC1Y area or any other competitors across 12 key performance metrics.
pollen health limited Ownership
POLLEN HEALTH LIMITED group structure
Pollen Health Limited has no subsidiary companies.
Ultimate parent company
2 parents
POLLEN HEALTH LIMITED
07839170
pollen health limited directors
Pollen Health Limited currently has 6 directors. The longest serving directors include Mr Jonathan Koch (Nov 2021) and Mrs Gail Flockhart (Nov 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Jonathan Koch | United Kingdom | 50 years | Nov 2021 | - | Director |
| Mrs Gail Flockhart | United Kingdom | 60 years | Nov 2021 | - | Director |
| Mr Brendan Ferretti | England | 45 years | Jun 2022 | - | Director |
| Mr John Gransee | United Kingdom | 59 years | Jan 2024 | - | Director |
| Mrs Harriet Shurville | United Kingdom | 38 years | Jan 2025 | - | Director |
| Amar Urhekar | United Kingdom | 50 years | Jan 2025 | - | Director |
P&L
March 2024turnover
3.8m
-8%
operating profit
779.2k
-27%
gross margin
35%
-16.33%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
3.7m
+0.26%
total assets
11.6m
+0.7%
cash
126.4k
-0.85%
net assets
Total assets minus all liabilities
pollen health limited company details
company number
07839170
Type
Private limited with Share Capital
industry
73110 - Advertising agencies
incorporation date
November 2011
age
14
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
the featherstone building, 66 city road, london, EC1Y 2AL
Bank
THE ROYAL BANK OF SCOTLAND PLC
Legal Advisor
-
pollen health limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pollen health limited.
pollen health limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for POLLEN HEALTH LIMITED. This can take several minutes, an email will notify you when this has completed.
pollen health limited Companies House Filings - See Documents
| date | description | view/download |
|---|
